Overview
Dakai Xiao practices practicing medicine in Guangzhou, China.
His clinical expertise encompasses Lung Adenocarcinoma, Lung Cancer, PIK3CA-Related Overgrowth Spectrum, and Non-Small Cell Lung Cancer (NSCLC).
He is actively involved in clinical research, co-authoring 22 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Dakai Q. Xiao
Is Dakai Q. Xiao a top-rated expert for Lung Adenocarcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dakai Q. Xiao is classified as an Experienced expert for Lung Adenocarcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Dakai Q. Xiao participate in research or clinical trials?
Yes. Dakai Q. Xiao has published 22 articles and abstracts on conditions like Lung Adenocarcinoma. You can view a list of Dakai Q. Xiao's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Lung AdenocarcinomaMr. Xiao isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerMr. Xiao isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Mr. Xiao isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- PIK3CA-Related Overgrowth SpectrumMr. Xiao isExperienced. Learn about PIK3CA-Related Overgrowth Spectrum.